D D Ross
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
-
- Acute Myeloid Leukemia Research
Papers in
- Oncology 10
- Drug Transport and Resistance Mechanisms 9
- Cancer Cells and Metastasis 1
-
- Chronic Myeloid Leukemia Treatments 2
- Acute Myeloid Leukemia Research 1
- Co-authors
- L. Austin Doyle (5 shared papers)Weidong Yang (4 shared papers)Lee M. Greenberger (2 shared papers)Sridhar K. Rabindran (1 shared paper)Erasmus Schneider (2 shared papers)Susan Elaine Bates (2 shared papers)Kenryu Nishiyama (1 shared paper)Thomas Litman (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (1 paper)British Journal of Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Leukemia (1 paper)Journal of Infection (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
D D Ross
14 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 53
- Oncology 1.2k
- Hematology 54
- Pharmacology 44
- Pharmacology 27
- Cancer Research 37
Countries citing papers authored by D D Ross
This map shows the geographic impact of D D Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D D Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D D Ross more than expected).
Fields of papers citing papers by D D Ross
This network shows the impact of papers produced by D D Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D D Ross. The network helps show where D D Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside D D Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. | 2000 | 431 |
| 2 | Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. | 2001 | 306 |
| 3 | 1999 | 297 | |
| 4 | Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. | 2000 | 106 |
| 5 | 2010 | 90 | |
| 6 | 2004 | 60 | |
| 7 | Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs. | 1998 | 46 |
| 8 | Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. | 1996 | 38 |
| 9 | Variation amongst K562 cell cultures. | 1983 | 27 |
| 10 | 1995 | 19 | |
| 11 | The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen. | 1997 | 16 |
| 12 | 2004 | 15 | |
| 13 | 2012 | 10 | |
| 14 | 1989 | 2 |
About D D Ross
D D Ross is a scholar working on Oncology, Hematology, Toxicology, Emergency Medicine and Immunology, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Chronic Myeloid Leukemia Treatments (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Mycobacterium research and diagnosis (1 paper), Cancer therapeutics and mechanisms (1 paper), Hematological disorders and diagnostics (1 paper), Acute Myeloid Leukemia Research (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Oncology (1.2k citations), Hematology (54 citations), Pharmacology (44 citations), Pharmacology (27 citations) and Cancer Research (37 citations). D D Ross has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include L. Austin Doyle, Weidong Yang, Lee M. Greenberger, Sridhar K. Rabindran, Erasmus Schneider, Susan Elaine Bates, Kenryu Nishiyama, Thomas Litman, Tyler J. Lahusen and Susan P.C. Cole. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, British Journal of Cancer, JNCI Journal of the National Cancer Institute, Leukemia and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.